BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE: HCC) (“Warrior” or the “Company”) today announced the recent publication of its 2024 sustainability report, now available on the Company's website at www.warriormetcoal.com/sustainability. The report details Warrior's commitment to sustainability principles. The report's highlights include: 19% improvement in safety incidence rate compared to 2023, Total incidence rate 65% lower than the national average for underground coal mines.

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 3:20 pm ET.

HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #analytics--BlackSky Technology Inc. (NYSE: BKSY) and Rocket Lab USA, Inc. (Nasdaq: RKLB) have established a launch window opening February 18 for the first Gen-3 satellite. The launch, named “Fasten Your Space Belts,” will add very high-resolution 35-centimeter imaging capability to BlackSky's high-cadence, low-latency data and AI-enabled analytics offerings. “This launch represents a major inflection point for our global defense and intelligence customer base as BlackSky in.

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Credit Company (NYSE: EARN) ("we") today announced that its Board of Trustees has declared a monthly common dividend of $0.08 per share, payable on March 25, 2025 to shareholders of record as of February 28, 2025. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking s.

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 105,100 shares of its common stock and granted an aggregate of 9,950 restricted stock unit (“RSU”) awards to 14 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq …

ROCKFORD, Mich. , Feb. 10, 2025 /PRNewswire/ -- Merrell, the world's leading hiking and outdoor footwear brand, announced it has welcomed Richard McLeod as Chief Marketing Officer.

The Wall Street Journal reports that an Elon Musk-led group is building a $97.4 billion bid to buy OpenAI. The development comes as Lyft Inc. (LYFT) races for a robotaxi launch in 2026 alongside Mobileye and Marubeni.

Vertex Pharmaceuticals (VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts' expectations.

TULSA, Okla.--(BUSINESS WIRE)--NGL Energy Partners LP Announces Third Quarter Fiscal 2025 Financial Results.

President Trump's tariffs on China remain, impacting trade dynamics, but Boeing is not significantly affected due to careful tariff crafting by China. The US-China trade deficit has decreased from $418 billion in 2018 to $295 billion in 2024, influenced by both tariffs and the pandemic. Boeing's role is crucial in reducing the trade deficit, with aerospace exports accounting for up to 15% of US exports to China.

Ideaya Biosciences, Inc.'s darovasertib + crizotinib combination is being explored in the potential registration-enabling phase 2/3 study targeting patients with 1st-line HLA-A2-negative metastatic uveal melanoma; mPFS data expected end of 2025. Darovasertib is also being evaluated in another phase 2 study as a monotherapy targeting neoadjuvant uveal melanoma patients, with data expected in 2025. The global uveal melanoma treatment market is projected to reach $3.22 billion by the end of 2034.

Bloomberg News Metals & Mining Reporter Joe Deaux joins Bloomberg Businessweek to discuss President Trump's plans to impose 25% tariffs on steel and aluminum imports. -------- More on Bloomberg Television and Markets Like this video?

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Watts Water Technologies Reports Fourth Quarter and Full Year 2024 Results.

PHILADELPHIA , Feb. 10, 2025 /PRNewswire/ -- The Board of Directors of FS Credit Opportunities Corp. (the Fund) (NYSE: FSCO) announced the monthly distribution for February 2025. The distribution of $0.0645 per share will be paid on February 28, 2025.

HOUSTON--(BUSINESS WIRE)---- $HESM--HESS MIDSTREAM LP ANNOUNCES SECONDARY PUBLIC OFFERING OF CLASS A SHARES.

'The Big Money Show' reacts to the high cost for a Disney vacation and the affordability for average American families.

DAVIDSON, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, will participate in fireside chats at the following upcoming investor conferences: The Citi Global Industrial Tech and Mobility Conference on Wednesday, February 19, 2025, at 11:20 a.m.

HONOLULU , Feb. 10, 2025 /PRNewswire/ -- Matson, Inc. ("Matson" or the "Company") (NYSE: MATX), a leading U.S. carrier in the Pacific, today announced that it will release its financial results for the fourth quarter on Tuesday, February 25, 2025. A conference call is scheduled for 4:30 p.m.

ROANOKE, Va., Feb. 10, 2025 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $5,269,689, or $0.51 per share, for the first quarter ended December 31, 2024, compared to $5,019,992, or $0.50 per share, for the fiscal quarter ended December 31, 2023.

AUSTIN, Texas--(BUSINESS WIRE)--Hyliion Holdings Corp. (NYSE American: HYLN), a developer of sustainable electricity-producing technology, today announced it will host a conference call and accompanying webcast at 10:00 a.m. CT / 11:00 a.m. ET on Wednesday, February 26, 2025, to discuss its financial results, the company's business, and outlook. Hyliion plans to report its 2024 fourth-quarter and full-year financial results after the market close on Tuesday, February 25, 2025. Hyliion's Fourth-.